Gastroenterology
Volume 134, Issue 4 , Pages 960-974.e8 , April 2008

Performance of Transient Elastography for the Staging of Liver Fibrosis: A Meta-Analysis

  • Mireen Friedrich–Rust

      Affiliations

    • Department of Internal Medicine I, J. W. Goethe-University Hospital, Frankfurt, Germany
    • ,
  • Mei–Fang Ong

      Affiliations

    • Faculty of Medicine, Internal Medicine-Biomathematics, Saarland University, Homburg, Germany
    • ,
  • Swantje Martens

      Affiliations

    • Faculty of Medicine, Internal Medicine-Biomathematics, Saarland University, Homburg, Germany
    • ,
  • Christoph Sarrazin

      Affiliations

    • Department of Internal Medicine I, J. W. Goethe-University Hospital, Frankfurt, Germany
    • ,
  • Joerg Bojunga

      Affiliations

    • Department of Internal Medicine I, J. W. Goethe-University Hospital, Frankfurt, Germany
    • ,
  • Stefan Zeuzem

      Affiliations

    • Department of Internal Medicine I, J. W. Goethe-University Hospital, Frankfurt, Germany
    • ,
  • Eva Herrmann

      Affiliations

    • Faculty of Medicine, Internal Medicine-Biomathematics, Saarland University, Homburg, Germany
    • Corresponding Author InformationAddress requests for reprints to: Eva Herrmann, PhD, Faculty of Medicine, Internal Medicine-Biomathematics, Saarland University, Kirrbergerstrasse, 66421 Homburg/Saar, Germany. fax: (49) (0)6841-16-23583.

Received 31 May 2007 ,Accepted 10 January 2008.

References 

  1. Lauer GM, Walker BD. Hepatitis C virus infection. N Engl J Med. 2001;345:41–52
  2. Strader DB, Wright T, Thomas DL, et al. American Association for the Study of Liver Diseases (Diagnosis, management, and treatment of hepatitis C). Hepatology. 2004;39:1147–1171
  3. Lok AS, McMahon BJ. Chronic hepatitis B. Hepatology. 2007;45:507–539
  4. Bravo AA, Sheth SG, Chopra S. Liver biopsy. N Engl J Med. 2001;344:495–500
  5. Bedossa P, Dargere D, Paradise V. Sampling variability of liver fibrosis in chronic hepatitis C. Hepatology. 2003;38:1449–1457
  6. Sandrin L, Fourquet B, Hasquenoph JM, et al. Transient elastography: a new non-invasive method for assessment of hepatic fibrosis. Ultrasound Med Biol. 2003;29:1705–1713
  7. Kettaneh A, Marcellin P, Douvin C, et al. Features associated with success rate and performance of Fibroscan measurements for the diagnosis of cirrhosis in HCV patients: a prospective study of 935 patients. J Hepatol. 2007;46:628–634
  8. Fraquelli M, Rigamonti C, Casazza G, et al. Reproducibility of transient elastography in the evaluation of liver fibrosis in patients with chronic liver disease. Gut. 2007;56:968–973
  9. Deeks JJ. Systematic reviews of evaluation of diagnostic and screening tests. BMJ. 2001;323:157–162
  10. Haynes RB, Wilczynski NL. Optimal search strategies for retrieving scientifically strong studies of diagnosis from Medline: analytical survey. BMJ. 2004;328:1040
  11. DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials. 1986;7:177–188
  12. Poynard T, Halfon P, Castera L, et al. Variability of the area under the receiver operating characteristic curves in the diagnostic evaluation of liver fibrosis markers: impact of biopsy length and fragmentation. Aliment Pharmacol Ther. 2007;25:733–739
  13. Poynard T, Halfon P, Castera L, et al. Standardization of ROC curve areas for diagnostic evaluation of liver fibrosis markers based on prevalences of fibrosis stages. Clin Chem. 2007;53:1615–1622
  14. Whiting P, Rutjes AW, Reitsma JB, et al. The development of QUADAS: a tool for the quality assessment of studies of diagnostic accuracy included in systematic reviews. BMC Med Res Methodol. 2003;3:25
  15. Littenberg B, Moses LE. Estimating diagnostic accuracy from multiple conflicting reports: a new meta-analytic method. Med Decis Making. 1993;13:313–321
  16. Carrion JA, Navasa M, Bosch J, et al. Transient elastography for diagnosis of advanced fibrosis and portal hypertension in patients with hepatitis C recurrence after liver transplantation. Liver Transpl. 2006;12:1791–1798
  17. Castera L, Vergniol J, Foucher J, et al. Prospective comparison of transient elastography, Fibrotest, APRI, and liver biopsy for the assessment of fibrosis in chronic hepatitis C. Gastroenterology. 2005;128:343–350
  18. Colletta C, Smirne C, Fabris C, et al. Value of two noninvasive methods to detect progression of fibrosis among HCV carriers with normal aminotransferases. Hepatology. 2005;42:838–845
  19. Corpechot C, El Naggar A, Poujol-Robert A, et al. Assessment of biliary fibrosis by transient elastography in patients with PBC and PSC. Hepatology. 2006;43:1118–1124
  20. De Ledinghen V, Douvin C, Kettaneh A, et al. Diagnosis of hepatic fibrosis and cirrhosis by transient elastography in HIV/hepatitis C virus-coinfected patients. J Acquir Immune Defic Syndr. 2006;41:175–179
  21. Erhardt A, Lorke J, Vogt C, et al. Transient elastography for diagnosing liver cirrhosis. Dtsch Med Wochenschr. 2006;131:2765–2769
  22. Ganne-Carrie N, Ziol M, de Ledinghen V, et al. Accuracy of liver stiffness measurement for the diagnosis of cirrhosis in patients with chronic liver diseases. Hepatology. 2006;44:1511–1517
  23. Gomez-Dominguez E, Mendoza J, Rubio S, et al. Transient elastography: a valid alternative to biopsy in patients with chronic liver disease. Aliment Pharmacol Ther. 2006;24:513–518
  24. Nahon P, Thabut G, Ziol M, et al. Liver stiffness measurement versus clinicians’ prediction or both for the assessment of liver fibrosis in patients with chronic hepatitis C. Am J Gastroenterol. 2006;101:2744–2751
  25. Posthouwer D, Mauser-Bunschoten EP, Fischer K, et al. Significant liver damage in patients with bleeding disorders and chronic hepatitis C: non-invasive assessment of liver fibrosis using transient elastography. J Thromb Haemost. 2007;5:25–30
  26. Ziol M, Handra-Luca A, Kettaneh A, et al. Noninvasive assessment of liver fibrosis by measurement of stiffness in patients with chronic hepatitis C. Hepatology. 2005;41:48–54
  27. Foucher J, Chanteloup E, Vergniol J, et al. Diagnosis of cirrhosis by transient elastography (FibroScan): a prospective study. Gut. 2006;55:403–408
  28. Takeda T, Yasuda T, Nakayama Y, et al. Usefulness of noninvasive transient elastography for assessment of liver fibrosis stage in chronic hepatitis C. World J Gastroenterol. 2006;12:7768–7773
  29. Baldaia C, Serejo F, Marinho R, et al. Transient elastography in chronic hepatitis C—comparison between different noninvasive methods for liver fibrosis assessment. Hepatology. 2006;44(Suppl 1):276A
  30. Barrault C, Medkour F, Atanaiu C, et al. Non invasive assessment of liver graft fibrosis by transient elastography after liver transplantation. Hepatology. 2005;42(suppl 1):485A–486A
  31. Blanc PL, Gabbuti A, Marino N, et al. Liver stiffness in chronic hepatitis C: will it modify the assessment of patients?. J Hepatol. 2007;46(suppl 1):S201A
  32. Castera L, Van hecke A, Trimoulet P, et al. Independent validation and comparison with FibroScan, FibroTest and liver biopsy of clinical glycomics for the non invasive assessment of liver fibrosis in chronic hepatitis C. Hepatology. 2005;42(Suppl 1):436A
  33. Castera L, Foucher J, Le Bail B, et al. Prospective and independent validation of the Lok index for prediction of cirrhosis in patients with chronic hepatitis C: comparison with FibroScan, FibroTest and APRI. DDW. 2006;(Abstract-ID: 552)
  34. Chang J, Tan HH, Yew BS, et al. Transient elastography (FibroScan®) to assess hepatic fibrosis in Chinese with chronic hepatitis B. 17th Asian Pacific Association for the Study of Liver Conference 2007.
  35. Chanteloup E, Foucher J, Castera L, et al. FibroScan® is a new non invasive method for the detection of cirrhosis and its complications in patients with chronic liver diseases. Results of a prospective study in 456 patients. Hepatology. 2004;40(suppl 1):515A
  36. Coco B, Oliveri F, Colombatto P, et al. Monitoring liver stiffness: a new tool to measure liver fibrosis during therapy. Hepatology. 2005;42(suppl 1):435A
  37. Coco B, Oliveri F, Colombatto B, et al. Liver stiffness measured by transient elastography: the influence of biochemical activity. J Hepatol. 2006;44(suppl 2):S196A
  38. Corradi F, Piscaglia F, Tame R, et al. Staging of hepatic fibrosis by liver elastometry (FibroScan) in recurrent HCV infection in liver transplant recipients. J Hepatol. 2006;44(suppl 2):S59A
  39. De Ledinghen V, Le Bail B, Rebouissoux L, et al. FibroScan® is a new non-invasive method for the diagnosis of liver fibrosis in children: a prospective comparison with FibroSure®, and liver biopsy. Hepatology. 2005;42(suppl 1):472A
  40. De Ledinghen V, Beaugrand M, Kelleher TB, et al. Prediction of liver fibrosis in non-alcoholic steatohepatitis (NASH): risk factors and diagnostic potential of liver elasticity using FibroScan. J Hepatol. 2006;44(suppl 2):S39A
  41. Foucher J, Vergniol J, Castera L, et al. Fibrosis evaluation in chronic liver diseases: comparison of FibroScan® with liver biopsy, FibroTest®, Forns score, APRI, hyaluronan, prothrombin time, and AST/ALT ratio. J Hepatol. 2005;42(suppl 2):78A
  42. Fraquelli M, Rigamonti C, Conte D, et al. Reproducibility of transient elastography (TE) in assessing hepatic fibrosis. Hepatology. 2006;44(suppl 1):444A
  43. Gaia S, Carenzi S, Brunello F, et al. Is liver stiffness measurement different in patients with NASH or with viral hepatitis?. J Hepatol. 2007;46(suppl 1):S268A
  44. Ganne-Carrie N, De Ledinghen V, Douvin C, et al. Accuracy of liver stiffness measurement (LSM) for the diagnosis of cirrhosis in patients with chronic liver diseases (CLD): a study in 1345 patients. Hepatology. 2005;42(suppl 1):338A
  45. Gomez-Dominguez E, Jimenez-Ridruejo JM, Monteagudo JAM, et al. Efficiency of liver stiffness measurement (FibroScan®) for the follow up of patients with primary biliary cirrhosis. Hepatology. 2006;44(suppl 1):633A
  46. Jeon SW, Cho CM, Park YD, et al. Correlation between liver elasticity measured by Fibroscan® and liver fibrosis assessed by histology; preliminary study in Korea. DDW. 2006;(Abstract ID: S1610)
  47. Khohkar A, Farnan R, MacFarlane C, et al. Liver stiffness and biomarkers: correlation with cirrhosis, portal hypertension and hepatic synthetic function. Hepatology. 2005;42(suppl 1):433A
  48. Kim KM, Park SH, Yu ES, et al. Diagnosis of hepatic steatosis and fibrosis by transient elastography in asymptomatic healthy people: a prospective study in potential living related liver donors. J Hepatol. 2006;44:S91A
  49. Laharie D, Foucher J, Bernard PH, et al. Assessment of cirrhosis and its severity by FibroScan and biochemical markers in alcoholic patients. DDW. 2006;(Abstract ID: M1026)
  50. Lewin M, Poujol-Robert A, Boelle PY, et al. Diffusion-weighted MR imaging for the diagnosis of liver fibrosis in patients with chronic hepatitis C. Hepatology. 2006;44(suppl 1):280A–281A
  51. Marcellin P, De Ledinghen V, Dhumeaux D, et al. Non-invasive assessment of liver fibrosis in chronic hepatitis B using FibroScan®. Hepatology. 2005;42(suppl 1):715A–716A
  52. Marin JC, De la Cruz J, Fernandez I, et al. Prospective comparison between transient elastography (FibroScan), APRI and Forns test for assessing liver fibrosis in patients with histological features of NAFLD. J Hepatol. 2007;46(suppl 1):S275A
  53. Miailhes P, Perrot G, Bailly F, et al. Prospective comparison of transient elastography and liver biopsy for the assessment of fibrosis in patients with HIV/HBV co-infection. 14th Conference on Retroviruses and Opportunistic Infections 2007.
  54. Nahon P, Ziol M, De Ledinghen V, et al. Assessment of liver fibrosis using liver stiffness measurement (LSM) in patients with alcoholic liver disease. J Hepatol. 2007;46(suppl 1):S278A
  55. Nguyen-Khac E, Robert B, Brevet M, et al. Assessment of asymptomatic liver fibrosis in alcohol abuser patients by transient elastography (FibroScan). J Hepatol. 2007;46(suppl 1):S280A
  56. Palau R, Mal F, Christidis C, et al. Transient elastography a new non invasive method for assessment of liver fibrosis: results in patients with HCV chronic hepatitis. J Hepatol. 2003;38(suppl 2):126A
  57. Pares A, Caballeria L, Lazaro E, et al. Transient elastography: a new and useful non-invasive method for assessing liver damage progression in primary biliary cirrhosis. Hepatology. 2005;42(suppl 1):464A
  58. Rigamonti C, Donato MF, Fraquelli M, et al. Evaluation of liver graft fibrosis by transient elastography (TE). Liver Transpl. 2006;12:C60A
  59. Rigamonti C, Donato F, Fraquelli M, et al. Transient elastography (TE, FibroScan®) in the evaluation of recurrent disease after liver transplantation (LT). Hepatology. 2006;44(suppl 1):195A
  60. Serejo F, Marinho R, Costa A, et al. Transient elastography (FibroScan®) in chronic hepatitis C (Will it modify the assessment and the follow-up of treated patients?). Hepatology. 2006;44(suppl 1):322A–323A
  61. Servin-Abad LA, Jeffers LJ, Bejarano P, et al. Correlation between liver histology, laparoscopic gross appearance and elasticity measured with the shear elasticity probe (FibroScan) in patients with chronic liver disease. Hepatology. 2006;44(suppl 1):578A
  62. Vergara S, Macías J, Rivero A, et al. Failure of transient elatometry (FibroScan) to differentiate mild from significant liver fibrosis in HIV/HCV-co-infected patients. 14th Conference on Retroviruses and Opportunistic Infections 2007.
  63. Beaugrand M, Ziol M, Sandrin L, et al. Liver elasticity measurement by ultrasonic transient elastography: a new non-invasive method for assessment of liver fibrosis in chronic viral hepatitis. Hepatology. 2003;38(suppl 1):438A–439A
  64. Swets JA. Measuring the accuracy of diagnostic systems. Science. 1988;240:1285–1293
  65. Ebell MH. Probability of cirrhosis in patients with hepatitis C. Am Fam Physician. 2003;68:1831–1833
  66. Veldt BJ, Heathcote EJ, Wedemeyer H, et al. Sustained virologic response and clinical outcomes in patients with chronic hepatitis C and advanced fibrosis. Ann Intern Med. 2007;147:677–684
  67. Siebert U, Sroczynski G. Effectiveness and cost-effectiveness of initial combination therapy with interferon/peginterferon plus ribavirin in patients with chronic hepatitis C in Germany: a health technology assessment commissioned by the German Federal Ministry of Health and Social Security. Int J Technol Assess Health Care. 2005;21:55–65
  68. Sebastiani G, Alberti A. Non invasive fibrosis biomarkers reduce but not substitute the need for liver biopsy. World J Gastroenterol. 2006;12:3682–3694
  69. Poynard T, Morra R, Halfon P, et al. Meta-analyses of Fibrotest diagnostic value in chronic liver disease. BMC Gastroenterol. 2007;7:40
  70. Poynard T, Munteanu M, Imbert-Bismut F, et al. Prospective analysis of discordant results between biochemical markers and biopsy in patients with chronic hepatitis C. Clin Chem. 2004;50:1344–1355
  71. Coco B, Oliveri F, Maina AM, et al. Transient elastography: a new surrogate marker of liver fibrosis influenced by major changes of transaminases. J Viral Hepat. 2007;14:360–369
  72. Castera L, Le-Bail B, Foucher J, et al. Prospective analysis of discordance between FibroScan and FibroTest when used in combination as first-line assessment of liver fibrosis in chronic hepatitis C. Hepatology. 2005;42(suppl 1):440A
  73. Hui SL, Zhou XH. Evaluation of diagnostic tests without gold standards. Stat Methods Med Res. 1998;7:354–370
  74. Ngo Y, Munteanu M, Messous D, et al. A prospective analysis of the prognostic value of biomarkers (FibroTest) in patients with chronic hepatitis C. Clin Chem. 2006;52:1887–1896

 This study was supported by the Federal Ministry of Education and Research (BMBF) program Kompetenznetz Hepatitis (Hep-Net).

PII: S0016-5085(08)00108-X

doi: 10.1053/j.gastro.2008.01.034

Gastroenterology
Volume 134, Issue 4 , Pages 960-974.e8 , April 2008

Article Tools

* Image Usage & Resolution